Comparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Fulcrum Therapeutics, Inc. ?
Unrated Stock - No Analysis Available
Quality key factors
Factor
Value
Sales Growth (5y)
-100.00%
EBIT Growth (5y)
-4.66%
EBIT to Interest (avg)
-79.38
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.98
Sales to Capital Employed (avg)
0.15
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0.14%
Valuation Key Factors 
Factor
Value
P/E Ratio
252
Industry P/E
Price to Book Value
1.71
EV to EBIT
-16.05
EV to EBITDA
-18.80
EV to Capital Employed
40.51
EV to Sales
2.09
PEG Ratio
2.48
Dividend Yield
NA
ROCE (Latest)
-252.38%
ROE (Latest)
0.68%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
Mildly Bullish
No Trend
Technical Movement
0What is working for the Company
NO KEY POSITIVE TRIGGERS
-16What is not working for the Company
PRE-TAX PROFIT(Q)
At USD -17.3 MM has Fallen at -4,554.86%
NET PROFIT(Q)
At USD -17.3 MM has Fallen at -4,554.86%
RAW MATERIAL COST(Y)
Grown by 101.02% (YoY
DEBTORS TURNOVER RATIO(HY)
Lowest at 0 times
Here's what is not working for Fulcrum Therapeutics, Inc.
Pre-Tax Profit
At USD -17.3 MM has Fallen at -4,554.86%
over average net sales of the previous four periods of USD 0.39 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (USD MM)
Net Profit
At USD -17.3 MM has Fallen at -4,554.86%
over average net sales of the previous four periods of USD 0.39 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Debtors Turnover Ratio
Lowest at 0 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Raw Material Cost
Grown by 101.02% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales






